Robert Hodgson – Publications — York Research Database

Phone(01904) 321069
Emailrob.hodgsonyork.acuk

Accepting PhD Students

If you made any changes in Pure these will be visible here soon.

34 Article
5 Commissioned report
3 Review article

3 results

Filter

2019

Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal
Claxton, L., O'Connor, J., Woolacott, N., Wright, K. & Hodgson, R., 1 May 2019, In: PharmacoEconomics. 37, 5, p. 645-654 10 p.
Research output: Contribution to journal › Review article › peer-review
Tisagenlecleucel for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia in People Aged up to 25 Years: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Walton, M., Sharif, S., Simmonds, M., Claxton, L. & Hodgson, R., 13 Apr 2019, In: PharmacoEconomics. 37, 10, p. 1209-1217 9 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
2017

Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Morgan, P. J., Woolacott, N. F., Biswas, M., Mebrahtu, T., Harden, M. & Hodgson, R., 24 Mar 2017, (E-pub ahead of print) In: PharmacoEconomics. p. 1-11 12 p.
Research output: Contribution to journal › Review article

Open Access
File